Identified sustained upregulation of the Arg1 marker in myeloid cells, purified from regrown tumors in the Gl261/C57Bl/6 mouse animal model, was found to be associated with low overall survival probability in GBM patients. The gene discussed is ARG1; the disease is glioblastoma.